32 Recruiting Trials

Clinical Trials
for Kidney Disease in Georgia

32 clinical trials for Kidney Disease are currently recruiting participants at study sites in Georgia. Study-related care is provided at no cost.

32
Recruiting trials
70
Study sites
26
Cities
20
Industry-sponsored
12
Phase 2
12
Phase 3

Kidney Disease clinical trials in Georgia: what to expect

Kidney disease trials are mostly for chronic kidney disease that is slowly getting worse, including kidney disease caused by diabetes. They test medicines meant to slow the decline in kidney function and protect the heart, usually on top of the standard blood pressure and diabetes treatments. Specific kidney diseases such as IgA nephropathy, FSGS and polycystic kidney disease now have many trials of their own, and separate studies enroll people on dialysis or living with a transplant.

In Georgia, recruiting kidney disease studies are concentrated in Atlanta, Decatur, East Point and Brunswick, with sites in 22 other cities. 20 of the 32 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who kidney disease trials usually look for

Trials describe kidney disease by two numbers: the filtration rate (eGFR) from a blood test and the amount of protein in the urine. Most enroll an eGFR between about 20 and 75 and a urine protein level above a cut-off, both measured at screening. Nearly all ask that you have taken a stable dose of a blood-pressure medicine of the ACE inhibitor or ARB type for three months, and many allow or require an SGLT2 inhibitor. IgA nephropathy and FSGS trials need a past kidney biopsy. Common exclusions are a transplant, dialysis and uncontrolled blood pressure.

What taking part involves

Screening includes blood and urine tests, sometimes a 24-hour urine collection, and a review of your records. Trials then run one to three years with visits every four to twelve weeks for labs and blood pressure, taking a study pill or injection added to your usual medicines; placebo arms are common and an extension often follows. Your nephrologist keeps managing your care. Study medicine and tests are free and visits are usually paid.

Questions worth asking the study team

Which stage the trial enrolls and whether you fit it; whether any of your medicines change; how often labs are needed; the chance of placebo; and whether you will be told your own kidney results during the study.

Showing 20 of 32 recruiting Kidney Disease trials in Georgia

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
NA Atlanta, Georgia +1 sites NCT06693661
This trial is looking for African American or Black adults with advanced chronic kidney disease. Participants will receive coaching to help manage their kidney health and may help delay the need for more intensive treatments.
Recruiting
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
PHASE3 Phoenix, Arizona +4 sites NCT05457283
This trial is looking for children and young adults aged 1 to 18 who have chronic kidney disease and proteinuria. Participants will take a treatment called finerenone alongside their current heart medicine for about 18 months.
Recruiting
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
PHASE3 Birmingham, Alabama +4 sites NCT07107945
This trial is looking for children aged 2 to 17 who have chronic kidney disease. Participants will take a daily tablet for 6 months followed by 1 year of another medication, with regular check-ups to monitor their health.
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
PHASE3 Huntsville, Alabama +4 sites NCT07753993
This trial is looking for adults with chronic kidney disease to see how well elecoglipron works compared to a placebo. Participants must be on certain medications for their condition before joining the study.
Recruiting
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
PHASE2 Atlanta, Georgia +1 sites NCT05928936
This trial is looking for people with chronic kidney disease who do not exercise regularly. Participants will help researchers understand how exercise impacts kidney health and explore possible therapies related to exercise.
Recruiting
Sympatholysis in Chronic Kidney Disease
PHASE1 Decatur, Georgia NCT02411773
This trial is looking for veterans with chronic kidney disease and kidney transplant recipients to understand their exercise limits and blood pressure changes during activity. Participants will need to exercise on a stationary bicycle as part of the study.
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
PHASE2 Decatur, Alabama +4 sites NCT05485961
This trial is looking for adults with end stage kidney disease who are undergoing dialysis and have systemic inflammation. Participants will receive a study medication or a placebo to see how it affects heart health.
Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
PHASE2 Huntsville, Alabama +4 sites NCT07271186
This trial is looking for adults with diabetic kidney disease to test some new medications. Participants will help researchers understand how safe and effective these medications are.
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3 Fairhope, Alabama +4 sites NCT06742723
This trial is looking for adults with chronic kidney disease and high blood pressure. If you join, you will take medications to see how they affect your kidney health and heart-related risks.
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
PHASE2 Alabaster, Alabama +4 sites NCT05312879
This trial is looking for adults and children with a specific type of kidney disease caused by genetics. Participants will receive the drug VX-147 to assess its effectiveness and safety.
Recruiting
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
PHASE2 Birmingham, Alabama +4 sites NCT06902558
This trial is looking for adults with a specific type of kidney disease. Participants will receive either the study drug or a placebo every 4 weeks for 92 weeks and will attend regular check-ups.
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
PHASE2 Decatur, Alabama +4 sites NCT06830629
This trial is looking for adults with a specific genetic risk for kidney disease and ongoing protein in their urine. Participants will take the drug MZE829 to see how it affects their kidney condition.
Recruiting
Ferric Citrate and Chronic Kidney Disease in Children
PHASE2 Atlanta, Georgia +4 sites NCT04741646
This trial is looking for children aged 6 to 18 with chronic kidney disease stages 3-4. Participants will take either ferric citrate or a placebo for 12 months to see how it affects their health.
Recruiting
Mindfulness in Chronic Kidney Disease
NA Atlanta, Georgia NCT04099992
This trial is looking for people with certain stages of chronic kidney disease who want to see if mindfulness meditation can help improve their health. Participants will also receive a type of nerve stimulation during the meditation.
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
PHASE3 Birmingham, Alabama +4 sites NCT06963827
This trial is looking for adults with a kidney condition called IgA nephropathy. Participants will receive either mezagitamab or a placebo for 22 weeks and then be monitored for about 1.5 years.
Recruiting
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
N/A Augusta, Georgia +4 sites NCT07059962
This trial is looking for adults with kidney disease who are on peritoneal dialysis. Participants will help explore a new way to predict health issues related to fluid overload.
Recruiting
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
N/A Atlanta, Georgia +4 sites NCT07006831
This trial is looking for kidney transplant patients to provide blood samples and information. The goal is to help develop a test that checks how well the transplanted kidney is functioning.
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
PHASE3 Decatur, Georgia +4 sites NCT05931276
This trial is looking for patients on hemodialysis who take certain beta blockers. Participants will receive either metoprolol or carvedilol to see how these medications affect heart health.
Recruiting
Incremental Hemodialysis: The TwoPlus Trial
NA Atlanta, Georgia +4 sites NCT05828823
This trial is looking for adults with kidney problems who need dialysis. Participants will either start a new type of dialysis called incremental hemodialysis or a traditional one. The trial will follow them for about two years to compare the outcomes.
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
PHASE3 Granada Hills, California +4 sites NCT06933472
This trial is looking for patients who are on dialysis and have high blood phosphate levels. Participants will take a medication called AP301 or a similar substance for a period of time to see if it helps lower their phosphate levels and improve their quality of life.
Recruiting

Where the Kidney Disease studies are in Georgia

  • Emory University, Atlanta3 trials
  • Research Site, East Point3 trials
  • Atlanta VA Medical Center, Decatur2 trials
  • Emory University Hospital, Atlanta2 trials
  • Emory University Hospital Midtown, Atlanta2 trials
  • Fides Clinical Research, Atlanta2 trials

Counts are recruiting studies listing at least one site in Georgia, from ClinicalTrials.gov, refreshed every two days.

Kidney Disease clinical trials in Georgia: common questions

How many Kidney Disease clinical trials are recruiting in Georgia?
TrialFinder currently lists 32 recruiting Kidney Disease clinical trials with study sites in Georgia. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Kidney Disease clinical trials located in Georgia?
Study sites for the Kidney Disease trials listed on this page include Atlanta, Decatur, Augusta. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Kidney Disease clinical trial in Georgia?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Kidney Disease trials in Georgia also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Kidney Disease clinical trial in Georgia?
Each study sets its own criteria based on age, Kidney Disease diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
What stage of kidney disease do trials look for?
Trials state an eGFR range and a urine protein threshold rather than a stage name; most cover stages 2 to 4. People on dialysis or with a transplant have separate trials written for them.
Do I need a kidney biopsy to join?
Trials for IgA nephropathy, FSGS and lupus nephritis require a past biopsy confirming the diagnosis. Trials for diabetic or general chronic kidney disease do not.
Will I keep my current kidney and blood pressure medicines?
Yes. Kidney trials add the study treatment to a stable regimen, usually including an ACE inhibitor or ARB, and your own nephrologist continues to manage them.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Kidney Disease trials near you in Georgia.

Get Matched — Free
No insurance required

Kidney disease trials evaluate SGLT2 inhibitors, dialysis protocols, renal transplant regimens, and supportive-care strategies for chronic and acute kidney disease.

All Kidney Disease trials →